The heart rate thermal component ( ) can increase with body heat accumulation and lead to work metabolism (WM) overestimation. We used two methods (VOGT and KAMP) to assess of 35 forest workers throughout their work shifts, then compared at work and at rest using limits of agreement (LoA). Next, for a subsample of 20 forest workers, we produced corrected WM estimates from and compared them to measured WM. Although both methods produced significantly different time-related profiles, they yielded comparable average thermal cardiac reactivity (VOGT: 24.8 bpm °C; KAMP: 24.5 bpm °C), average (LoA: 0.7 ± 11.2 bpm) and average WM estimates (LoA: 0.2 ± 3.4 ml O kgmin for VOGT, and 0.0 ± 5.4 ml O kgmin for KAMP). Both methods are suitable to assess heat stress through and improve WM estimation. We compared two methods for assessing the heart rate thermal component ( ), which is needed to produce a corrected HR profile for estimating work metabolism (WM). Both methods yielded similar estimates that allowed accurate estimations of heat stress and WM at the group level, but they were imprecise at the individual level. AIC: akaike information criterion; bpm: beats per minute; CI: confidence intervals; CV: coefficient of variation in %; CV drift: cardiovascular drift; ΔHR: the heart rate thermal component in bpm; ΔHR: the heart rate thermal component in bpm; ΔΔHR: variation in the heart rate thermal component in bpm; ΔT: variation in core body temperature in °C; HR: heart rate in bpm; HRmax: maximal heart rate in bpm; Icl: cloting insulation in clo; KAMP: Kampmann et al. (2001) method to determe ΔHR; LoA: Limits of Agreement; PMV-PPD: the Predicted Mean Vote and Predicted Percentage Dissatisfied; PHS: Predicted Heat Strain model; RCM: random coefficients model; SD: standard deviation; TC: core body temperature in °C; TCR: thermal cardiac reactivity in bpm °C; τ: rate of change in the heart rate thermal component in bpm min; τ: rate of change in core body temperature in °C min; t: Student's t statistic with level of confidence alpha and n degrees of freedom; TWL: Thermal Work Limit model; : oxygen consumption in ml O kg min; max: maximal oxygen consumption in ml O kg min; VOGT: Vogt et al. (1973) method to determine ΔHR; WBGT: Wet-Bulb Globe Temperature in °C; WM: work metabolism.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/00140139.2019.1588386 | DOI Listing |
Clin Lung Cancer
December 2024
Department of Thoracic Surgery, Liverpool Heart and Lung Hospital, Liverpool, UK.
Background: To evaluate the real-world surgical and pathological outcomes following neoadjuvant nivolumab in combination with chemotherapy in a multicentre national cohort of patients.
Methods: Retrospective analysis on consecutive patients treated in three tertiary referral hospitals in UK with neoadjuvant chemotherapy and immunotherapy (nivolumab) for stage II-IIIB nonsmall cell lung cancer (March 2023-May 2024). Surgical and pathological outcomes were assessed.
J Cardiol
January 2025
Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan. Electronic address:
Background: Despite increasing awareness in general practice, heart failure with preserved ejection fraction (HFpEF) remains under-diagnosed in the community due to diagnostic difficulties. Dedicated dyspnea clinics are responsible for diagnosing HFpEF and efficient referral from primary care physicians is the key to enhance its role.
Methods: This retrospective analysis was performed to assess the effectiveness of a one-year collaborative project between our dyspnea clinic and the Maebashi Medical Association.
J Am Soc Echocardiogr
January 2025
Cardiology Clinic, University Center Serbia, Medical School, University Clinical Center Serbia, University of Belgrade, Serbia.
Background: Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous entity including patients with different phenotypes of near normal, normal, and supernormal left ventricular (LV) function.
Objectives: To assess the value of resting LV elastance (also known as force) with transthoracic echocardiography (TTE) to identify HFpEF phenotypes.
Methods: In a prospective, observational, multicenter study, 2380 HFpEF patients were recruited from July 2016 to May 2024.
Ann Epidemiol
January 2025
IRCCS Centro Cardiologico Monzino, Department of Cardiovascular Surgery, 20138 Milan, Italy; Department of Biomedical, Surgical and Dental Sciences, University of Milan, 20100 Milan, Italy.
Purpose: To compare the overall survival and the risk of all-cause and heart failure-specific hospitalization in nonagenarian patients hospitalized for symptomatic severe aortic stenosis (AS) who underwent transcatheter aortic valve implantation (TAVI) or conservative treatment.
Methods: Population-based retrospective cohort study based on healthcare utilization databases of the Italian region of Lombardy. The cohort included all nonagenarians hospitalized for AS between 2017 and 2021, who underwent TAVI within 90 days from first diagnosis or conservative treatment.
Lancet Diabetes Endocrinol
January 2025
British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK. Electronic address:
Background: Data on the effect of mineralocorticoid receptor antagonist therapy on HbA levels and new-onset diabetes are conflicting. We aimed to examine the effect of oral finerenone, compared with placebo, on incident diabetes in the Finerenone Trial to Investigate Efficacy and Safety Superior to Placebo in Patients with Heart Failure (FINEARTS-HF) trial.
Methods: In this randomised, double-blind, placebo-controlled trial, 6001 participants with heart failure with New York Heart Association functional class II-IV, left ventricular ejection fraction 40% or higher, evidence of structural heart disease, and elevated N-terminal pro-B-type natriuretic peptide levels were randomly assigned to finerenone or placebo, administered orally.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!